KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Amortizatization of Intangibles (2019 - 2021)

Palvella Therapeutics (PVLA) has disclosed Amortizatization of Intangibles for 3 consecutive years, with -$23000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Amortizatization of Intangibles rose 46.51% to -$23000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was -$388000.0, a 211.17% decrease, with the full-year FY2021 number at -$91000.0, up 50.54% from a year prior.
  • Amortizatization of Intangibles was -$23000.0 for Q2 2021 at Palvella Therapeutics, up from -$25000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $215000.0 in Q2 2019 to a low of -$259000.0 in Q3 2020.
  • A 3-year average of $19555.6 and a median of -$23000.0 in 2021 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: tumbled 359.0% in 2020, then soared 46.51% in 2021.
  • Palvella Therapeutics' Amortizatization of Intangibles stood at $93000.0 in 2019, then crashed by 187.1% to -$81000.0 in 2020, then soared by 71.6% to -$23000.0 in 2021.
  • Per Business Quant, the three most recent readings for PVLA's Amortizatization of Intangibles are -$23000.0 (Q2 2021), -$25000.0 (Q1 2021), and -$81000.0 (Q4 2020).